Rigel Pharmaceuticals
RIGL
RIGL
131 hedge funds and large institutions have $447M invested in Rigel Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 58 increasing their positions, 20 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0.25% more ownership
Funds ownership: 9.41% → 9.65% (+0.25%)
9% less capital invested
Capital invested by funds: $490M → $447M (-$43.5M)
Holders
131
Holding in Top 10
–
Calls
$831K
Puts
$782K
Top Buyers
| 1 | +$8.53M | |
| 2 | +$8.48M | |
| 3 | +$7.43M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.93M |
| 5 |
BlackRock
New York
|
+$6.54M |
Top Sellers
| 1 | -$14.6M | |
| 2 | -$7.98M | |
| 3 | -$4.18M | |
| 4 |
JGC
J. Goldman & Co
New York
|
-$2.95M |
| 5 |
Renaissance Technologies
New York
|
-$2.44M |